{
  "DOI": "10.1016/j.ajhg.2019.02.003",
  "ISSN": [
    "0002-9297"
  ],
  "URL": "http://dx.doi.org/10.1016/j.ajhg.2019.02.003",
  "alternative-id": [
    "S0002929719300485"
  ],
  "assertion": [
    {
      "label": "This article is maintained by",
      "name": "publisher",
      "value": "Elsevier"
    },
    {
      "label": "Article Title",
      "name": "articletitle",
      "value": "Systemic mRNA Therapy for the Treatment of Fabry Disease: Preclinical Studies in Wild-Type Mice, Fabry Mouse Model, and Wild-Type Non-human Primates"
    },
    {
      "label": "Journal Title",
      "name": "journaltitle",
      "value": "The American Journal of Human Genetics"
    },
    {
      "label": "CrossRef DOI link to publisher maintained version",
      "name": "articlelink",
      "value": "https://doi.org/10.1016/j.ajhg.2019.02.003"
    },
    {
      "label": "Content Type",
      "name": "content_type",
      "value": "article"
    },
    {
      "label": "Copyright",
      "name": "copyright",
      "value": "© 2019 American Society of Human Genetics."
    }
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Zhu",
      "given": "Xuling",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Yin",
      "given": "Ling",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Theisen",
      "given": "Matt",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Zhuo",
      "given": "Jenny",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Siddiqui",
      "given": "Summar",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Levy",
      "given": "Becca",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Presnyak",
      "given": "Vladimir",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Frassetto",
      "given": "Andrea",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Milton",
      "given": "Jaclyn",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Salerno",
      "given": "Timothy",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Benenato",
      "given": "Kerry E.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Milano",
      "given": "Joe",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Lynn",
      "given": "Andy",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Sabnis",
      "given": "Staci",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Burke",
      "given": "Kristine",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Besin",
      "given": "Gilles",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Lukacs",
      "given": "Christine M.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Guey",
      "given": "Lin T.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Finn",
      "given": "Patrick F.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Martini",
      "given": "Paolo G.V.",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "The American Journal of Human Genetics"
  ],
  "content-domain": {
    "crossmark-restriction": true,
    "domain": [
      "ajhg.org",
      "elsevier.com",
      "sciencedirect.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2019,
        3,
        14
      ]
    ],
    "date-time": "2019-03-14T11:44:02Z",
    "timestamp": 1552563842000
  },
  "deposited": {
    "date-parts": [
      [
        2019,
        10,
        3
      ]
    ],
    "date-time": "2019-10-03T20:54:45Z",
    "timestamp": 1570136085000
  },
  "indexed": {
    "date-parts": [
      [
        2024,
        4,
        26
      ]
    ],
    "date-time": "2024-04-26T05:10:39Z",
    "timestamp": 1714108239108
  },
  "is-referenced-by-count": 101,
  "issn-type": [
    {
      "type": "print",
      "value": "0002-9297"
    }
  ],
  "issue": "4",
  "issued": {
    "date-parts": [
      [
        2019,
        4
      ]
    ]
  },
  "journal-issue": {
    "issue": "4",
    "published-print": {
      "date-parts": [
        [
          2019,
          4
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "https://www.elsevier.com/tdm/userlicense/1.0/",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2019,
            4,
            1
          ]
        ],
        "date-time": "2019-04-01T00:00:00Z",
        "timestamp": 1554076800000
      }
    },
    {
      "URL": "http://www.elsevier.com/open-access/userlicense/1.0/",
      "content-version": "vor",
      "delay-in-days": 186,
      "start": {
        "date-parts": [
          [
            2019,
            10,
            4
          ]
        ],
        "date-time": "2019-10-04T00:00:00Z",
        "timestamp": 1570147200000
      }
    }
  ],
  "link": [
    {
      "URL": "https://api.elsevier.com/content/article/PII:S0002929719300485?httpAccept=text/xml",
      "content-type": "text/xml",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://api.elsevier.com/content/article/PII:S0002929719300485?httpAccept=text/plain",
      "content-type": "text/plain",
      "content-version": "vor",
      "intended-application": "text-mining"
    }
  ],
  "member": "78",
  "page": "625-637",
  "prefix": "10.1016",
  "published": {
    "date-parts": [
      [
        2019,
        4
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2019,
        4
      ]
    ]
  },
  "publisher": "Elsevier BV",
  "reference": [
    {
      "DOI": "10.1016/j.ymgme.2006.11.008",
      "article-title": "Cellular and tissue distribution of intravenously administered agalsidase alfa",
      "author": "Murray",
      "doi-asserted-by": "crossref",
      "first-page": "307",
      "journal-title": "Mol. Genet. Metab.",
      "key": "10.1016/j.ajhg.2019.02.003_bib1",
      "volume": "90",
      "year": "2007"
    },
    {
      "DOI": "10.1001/jama.284.21.2771",
      "article-title": "Clinical features of and recent advances in therapy for Fabry disease",
      "author": "Brady",
      "doi-asserted-by": "crossref",
      "first-page": "2771",
      "journal-title": "JAMA",
      "key": "10.1016/j.ajhg.2019.02.003_bib2",
      "volume": "284",
      "year": "2000"
    },
    {
      "DOI": "10.1016/j.cca.2017.01.018",
      "article-title": "Biomarkers associated with clinical manifestations in Fabry disease patients with a late-onset cardiac variant mutation",
      "author": "Auray-Blais",
      "doi-asserted-by": "crossref",
      "first-page": "185",
      "journal-title": "Clin. Chim. Acta",
      "key": "10.1016/j.ajhg.2019.02.003_bib3",
      "volume": "466",
      "year": "2017"
    },
    {
      "DOI": "10.1371/journal.pone.0144958",
      "article-title": "Distributions of globotriaosylceramide isoforms, and globotriaosylsphingosine and its analogues in an α-galactosidase A knockout mouse, a model of Fabry disease",
      "author": "Sueoka",
      "doi-asserted-by": "crossref",
      "first-page": "e0144958",
      "journal-title": "PLoS ONE",
      "key": "10.1016/j.ajhg.2019.02.003_bib4",
      "volume": "10",
      "year": "2015"
    },
    {
      "DOI": "10.1371/journal.pone.0127048",
      "article-title": "Nano-LC-MS/MS for quantification of Lyso-Gb3 and its analogues reveals a useful biomarker for Fabry disease",
      "author": "Sueoka",
      "doi-asserted-by": "crossref",
      "first-page": "e0127048",
      "journal-title": "PLoS ONE",
      "key": "10.1016/j.ajhg.2019.02.003_bib5",
      "volume": "10",
      "year": "2015"
    },
    {
      "DOI": "10.1016/j.cca.2012.09.026",
      "article-title": "LC-MS/MS analysis of plasma lyso-Gb3 in Fabry disease",
      "author": "Boutin",
      "doi-asserted-by": "crossref",
      "first-page": "273",
      "journal-title": "Clin. Chim. Acta",
      "key": "10.1016/j.ajhg.2019.02.003_bib6",
      "volume": "414",
      "year": "2012"
    },
    {
      "DOI": "10.1093/ndt/gfx319",
      "article-title": "Fabry disease under enzyme replacement therapy-new insights in efficacy of different dosages",
      "author": "Krämer",
      "doi-asserted-by": "crossref",
      "first-page": "1362",
      "journal-title": "Nephrol. Dial. Transplant.",
      "key": "10.1016/j.ajhg.2019.02.003_bib7",
      "volume": "33",
      "year": "2017"
    },
    {
      "DOI": "10.1016/j.retram.2016.09.001",
      "article-title": "Fabry disease: A fundamental genetic modifier of cardiac function",
      "author": "Tadevosyan",
      "doi-asserted-by": "crossref",
      "first-page": "10",
      "journal-title": "Curr. Res. Transl. Med.",
      "key": "10.1016/j.ajhg.2019.02.003_bib8",
      "volume": "65",
      "year": "2017"
    },
    {
      "DOI": "10.1007/s12574-017-0340-x",
      "article-title": "Fabry disease",
      "author": "Yuasa",
      "doi-asserted-by": "crossref",
      "first-page": "151",
      "journal-title": "J. Echocardiogr.",
      "key": "10.1016/j.ajhg.2019.02.003_bib9",
      "volume": "15",
      "year": "2017"
    },
    {
      "DOI": "10.1111/dmcn.13600",
      "article-title": "Treatment strategies for lysosomal storage disorders",
      "author": "Beck",
      "doi-asserted-by": "crossref",
      "first-page": "13",
      "journal-title": "Dev. Med. Child Neurol.",
      "key": "10.1016/j.ajhg.2019.02.003_bib10",
      "volume": "60",
      "year": "2018"
    },
    {
      "DOI": "10.2174/1875397301004010050",
      "article-title": "Fabry disease - current treatment and new drug development",
      "author": "Motabar",
      "doi-asserted-by": "crossref",
      "first-page": "50",
      "journal-title": "Curr. Chem. Genomics",
      "key": "10.1016/j.ajhg.2019.02.003_bib11",
      "volume": "4",
      "year": "2010"
    },
    {
      "DOI": "10.1002/jgf2.76",
      "article-title": "Fabry disease and its cardiac involvement",
      "author": "Kubo",
      "doi-asserted-by": "crossref",
      "first-page": "225",
      "journal-title": "J. Gen. Fam. Med.",
      "key": "10.1016/j.ajhg.2019.02.003_bib12",
      "volume": "18",
      "year": "2017"
    },
    {
      "DOI": "10.1001/jama.281.3.249",
      "article-title": "Prevalence of lysosomal storage disorders",
      "author": "Meikle",
      "doi-asserted-by": "crossref",
      "first-page": "249",
      "journal-title": "JAMA",
      "key": "10.1016/j.ajhg.2019.02.003_bib13",
      "volume": "281",
      "year": "1999"
    },
    {
      "DOI": "10.1172/jci.insight.99171",
      "article-title": "Neuropathic pain in a Fabry disease rat model",
      "author": "Miller",
      "doi-asserted-by": "crossref",
      "first-page": "e99171",
      "journal-title": "JCI Insight",
      "key": "10.1016/j.ajhg.2019.02.003_bib14",
      "volume": "3",
      "year": "2018"
    },
    {
      "DOI": "10.1016/j.ymgme.2016.05.015",
      "article-title": "Pilot study of newborn screening for six lysosomal storage diseases using Tandem Mass Spectrometry",
      "author": "Elliott",
      "doi-asserted-by": "crossref",
      "first-page": "304",
      "journal-title": "Mol. Genet. Metab.",
      "key": "10.1016/j.ajhg.2019.02.003_bib15",
      "volume": "118",
      "year": "2016"
    },
    {
      "DOI": "10.1086/504601",
      "article-title": "High incidence of later-onset fabry disease revealed by newborn screening",
      "author": "Spada",
      "doi-asserted-by": "crossref",
      "first-page": "31",
      "journal-title": "Am. J. Hum. Genet.",
      "key": "10.1016/j.ajhg.2019.02.003_bib16",
      "volume": "79",
      "year": "2006"
    },
    {
      "DOI": "10.1136/jmedgenet-2014-102797",
      "article-title": "Ten-year outcome of enzyme replacement therapy with agalsidase beta in patients with Fabry disease",
      "author": "Germain",
      "doi-asserted-by": "crossref",
      "first-page": "353",
      "journal-title": "J. Med. Genet.",
      "key": "10.1016/j.ajhg.2019.02.003_bib17",
      "volume": "52",
      "year": "2015"
    },
    {
      "DOI": "10.1016/j.ymgme.2012.11.109",
      "article-title": "Evaluation of long-term enzyme replacement therapy for children with Fabry disease",
      "author": "Hebert",
      "doi-asserted-by": "crossref",
      "first-page": "S47",
      "journal-title": "Mol. Genet. Metab.",
      "key": "10.1016/j.ajhg.2019.02.003_bib18",
      "volume": "108",
      "year": "2013"
    },
    {
      "DOI": "10.1155/2013/282487",
      "article-title": "Long-term effect of enzyme replacement therapy with fabry disease",
      "author": "Komori",
      "doi-asserted-by": "crossref",
      "first-page": "282487",
      "journal-title": "Int. J. Otolaryngol.",
      "key": "10.1016/j.ajhg.2019.02.003_bib19",
      "volume": "2013",
      "year": "2013"
    },
    {
      "DOI": "10.1007/s11547-011-0710-9",
      "article-title": "Role of cardiac MRI in evaluating patients with Anderson-Fabry disease: assessing cardiac effects of long-term enzyme replacement therapy",
      "author": "Messalli",
      "doi-asserted-by": "crossref",
      "first-page": "19",
      "journal-title": "Radiol. Med. (Torino)",
      "key": "10.1016/j.ajhg.2019.02.003_bib20",
      "volume": "117",
      "year": "2012"
    },
    {
      "DOI": "10.1161/CIRCULATIONAHA.108.794529",
      "article-title": "Long-term effects of enzyme replacement therapy on fabry cardiomyopathy: evidence for a better outcome with early treatment",
      "author": "Weidemann",
      "doi-asserted-by": "crossref",
      "first-page": "524",
      "journal-title": "Circulation",
      "key": "10.1016/j.ajhg.2019.02.003_bib21",
      "volume": "119",
      "year": "2009"
    },
    {
      "DOI": "10.1016/j.hoc.2017.05.002",
      "article-title": "Therapeutic gene editing safety and specificity",
      "author": "Lux",
      "doi-asserted-by": "crossref",
      "first-page": "787",
      "journal-title": "Hematol. Oncol. Clin. North Am.",
      "key": "10.1016/j.ajhg.2019.02.003_bib22",
      "volume": "31",
      "year": "2017"
    },
    {
      "DOI": "10.1111/febs.13760",
      "article-title": "Off-target effects of engineered nucleases",
      "author": "Yee",
      "doi-asserted-by": "crossref",
      "first-page": "3239",
      "journal-title": "FEBS J.",
      "key": "10.1016/j.ajhg.2019.02.003_bib23",
      "volume": "283",
      "year": "2016"
    },
    {
      "DOI": "10.1038/nrd4278",
      "article-title": "mRNA-based therapeutics--developing a new class of drugs",
      "author": "Sahin",
      "doi-asserted-by": "crossref",
      "first-page": "759",
      "journal-title": "Nat. Rev. Drug Discov.",
      "key": "10.1016/j.ajhg.2019.02.003_bib24",
      "volume": "13",
      "year": "2014"
    },
    {
      "DOI": "10.1016/j.celrep.2017.11.081",
      "article-title": "Systemic messenger RNA therapy as a treatment for methylmalonic acidemia",
      "author": "An",
      "doi-asserted-by": "crossref",
      "first-page": "3548",
      "journal-title": "Cell Rep.",
      "key": "10.1016/j.ajhg.2019.02.003_bib25",
      "volume": "21",
      "year": "2017"
    },
    {
      "DOI": "10.1038/s41591-018-0199-z",
      "article-title": "Systemic messenger RNA as an etiological treatment for acute intermittent porphyria",
      "author": "Jiang",
      "doi-asserted-by": "crossref",
      "first-page": "1899",
      "journal-title": "Nat. Med.",
      "key": "10.1016/j.ajhg.2019.02.003_bib26",
      "volume": "24",
      "year": "2018"
    },
    {
      "DOI": "10.1016/j.ajpath.2014.11.004",
      "article-title": "α-Galactosidase A knockout mice: progressive organ pathology resembles the type 2 later-onset phenotype of Fabry disease",
      "author": "Bangari",
      "doi-asserted-by": "crossref",
      "first-page": "651",
      "journal-title": "Am. J. Pathol.",
      "key": "10.1016/j.ajhg.2019.02.003_bib27",
      "volume": "185",
      "year": "2015"
    },
    {
      "DOI": "10.1016/j.cell.2017.06.040",
      "article-title": "Vaccine mediated protection against Zika virus-induced congenital disease",
      "author": "Richner",
      "doi-asserted-by": "crossref",
      "first-page": "273",
      "journal-title": "Cell",
      "key": "10.1016/j.ajhg.2019.02.003_bib28",
      "volume": "170",
      "year": "2017"
    },
    {
      "DOI": "10.1016/j.cell.2017.02.017",
      "article-title": "Modified mRNA vaccines protect against Zika virus infection",
      "author": "Richner",
      "doi-asserted-by": "crossref",
      "first-page": "1114",
      "journal-title": "Cell",
      "key": "10.1016/j.ajhg.2019.02.003_bib29",
      "volume": "168",
      "year": "2017"
    },
    {
      "DOI": "10.1016/j.ymthe.2018.03.010",
      "article-title": "A novel amino lipid series for mRNA delivery: improved endosomal escape and sustained pharmacology and safety in non-human primates",
      "author": "Sabnis",
      "doi-asserted-by": "crossref",
      "first-page": "1509",
      "journal-title": "Mol. Ther.",
      "key": "10.1016/j.ajhg.2019.02.003_bib30",
      "volume": "26",
      "year": "2018"
    },
    {
      "DOI": "10.1124/jpet.108.149054",
      "article-title": "Preclinical efficacy and safety of 1-deoxygalactonojirimycin in mice for Fabry disease",
      "author": "Ishii",
      "doi-asserted-by": "crossref",
      "first-page": "723",
      "journal-title": "J. Pharmacol. Exp. Ther.",
      "key": "10.1016/j.ajhg.2019.02.003_bib31",
      "volume": "328",
      "year": "2009"
    },
    {
      "DOI": "10.1021/ac203433e",
      "article-title": "Urinary globotriaosylsphingosine-related biomarkers for Fabry disease targeted by metabolomics",
      "author": "Auray-Blais",
      "doi-asserted-by": "crossref",
      "first-page": "2745",
      "journal-title": "Anal. Chem.",
      "key": "10.1016/j.ajhg.2019.02.003_bib32",
      "volume": "84",
      "year": "2012"
    },
    {
      "DOI": "10.1016/j.ymgme.2016.11.160",
      "article-title": "Liver-based expression of the human alpha-galactosidase A gene (GLA) in a murine Fabry model results in continuous supra-physiological enzyme activity and effective substrate reduction",
      "author": "Huston",
      "doi-asserted-by": "crossref",
      "first-page": "S69",
      "journal-title": "Mol. Genet. Metab.",
      "key": "10.1016/j.ajhg.2019.02.003_bib33",
      "volume": "120",
      "year": "2017"
    },
    {
      "DOI": "10.1007/s10545-015-9886-9",
      "article-title": "Mannose receptor-mediated delivery of moss-made α-galactosidase A efficiently corrects enzyme deficiency in Fabry mice",
      "author": "Shen",
      "doi-asserted-by": "crossref",
      "first-page": "293",
      "journal-title": "J. Inherit. Metab. Dis.",
      "key": "10.1016/j.ajhg.2019.02.003_bib34",
      "volume": "39",
      "year": "2016"
    },
    {
      "DOI": "10.1016/j.ymgme.2014.08.002",
      "article-title": "Characterization of a chemically modified plant cell culture expressed human α-Galactosidase-A enzyme for treatment of Fabry disease",
      "author": "Kizhner",
      "doi-asserted-by": "crossref",
      "first-page": "259",
      "journal-title": "Mol. Genet. Metab.",
      "key": "10.1016/j.ajhg.2019.02.003_bib35",
      "volume": "114",
      "year": "2015"
    },
    {
      "DOI": "10.1038/mt.2015.87",
      "article-title": "Coformulation of a novel human α-Galactosidase A with the pharmacological chaperone AT1001 leads to improved substrate reduction in Fabry mice",
      "author": "Xu",
      "doi-asserted-by": "crossref",
      "first-page": "1169",
      "journal-title": "Mol. Ther.",
      "key": "10.1016/j.ajhg.2019.02.003_bib36",
      "volume": "23",
      "year": "2015"
    },
    {
      "DOI": "10.1038/mt.2011.271",
      "article-title": "Co-administration with the pharmacological chaperone AT1001 increases recombinant human α-galactosidase A tissue uptake and improves substrate reduction in Fabry mice",
      "author": "Benjamin",
      "doi-asserted-by": "crossref",
      "first-page": "717",
      "journal-title": "Mol. Ther.",
      "key": "10.1016/j.ajhg.2019.02.003_bib37",
      "volume": "20",
      "year": "2012"
    },
    {
      "DOI": "10.1016/j.ymthe.2003.11.015",
      "article-title": "AAV2 vector harboring a liver-restricted promoter facilitates sustained expression of therapeutic levels of α-galactosidase A and the induction of immune tolerance in Fabry mice",
      "author": "Ziegler",
      "doi-asserted-by": "crossref",
      "first-page": "231",
      "journal-title": "Mol. Ther.",
      "key": "10.1016/j.ajhg.2019.02.003_bib38",
      "volume": "9",
      "year": "2004"
    },
    {
      "DOI": "10.1089/10430349950017671",
      "article-title": "Correction of enzymatic and lysosomal storage defects in Fabry mice by adenovirus-mediated gene transfer",
      "author": "Ziegler",
      "doi-asserted-by": "crossref",
      "first-page": "1667",
      "journal-title": "Hum. Gene Ther.",
      "key": "10.1016/j.ajhg.2019.02.003_bib39",
      "volume": "10",
      "year": "1999"
    },
    {
      "DOI": "10.1007/s10038-005-0342-9",
      "article-title": "Comparison of the effects of agalsidase alfa and agalsidase beta on cultured human Fabry fibroblasts and Fabry mice",
      "author": "Sakuraba",
      "doi-asserted-by": "crossref",
      "first-page": "180",
      "journal-title": "J. Hum. Genet.",
      "key": "10.1016/j.ajhg.2019.02.003_bib40",
      "volume": "51",
      "year": "2006"
    },
    {
      "article-title": "Fabry disease and the heart. Best Pract. Res. Clin. Endocrinol",
      "author": "Seydelmann",
      "first-page": "195",
      "journal-title": "Metab.",
      "key": "10.1016/j.ajhg.2019.02.003_bib41",
      "volume": "29",
      "year": "2014"
    },
    {
      "DOI": "10.1111/cge.12386",
      "article-title": "The kidney in Fabry’s disease",
      "author": "Pisani",
      "doi-asserted-by": "crossref",
      "first-page": "301",
      "journal-title": "Clin. Genet.",
      "key": "10.1016/j.ajhg.2019.02.003_bib42",
      "volume": "86",
      "year": "2014"
    },
    {
      "article-title": "The kidney in Fabry disease: more than mere sphingolipids overload",
      "author": "Trimarchi",
      "journal-title": "J. Inborn Errors Metab.",
      "key": "10.1016/j.ajhg.2019.02.003_bib43",
      "volume": "Screening 4",
      "year": "2016"
    },
    {
      "DOI": "10.1086/316953",
      "article-title": "Fabry disease: preclinical studies demonstrate the effectiveness of alpha-galactosidase A replacement in enzyme-deficient mice",
      "author": "Ioannou",
      "doi-asserted-by": "crossref",
      "first-page": "14",
      "journal-title": "Am. J. Hum. Genet.",
      "key": "10.1016/j.ajhg.2019.02.003_bib44",
      "volume": "68",
      "year": "2001"
    },
    {
      "DOI": "10.1093/ndt/gfy146.FP805",
      "article-title": "Progression of nephropathy in Fabry patients receiving enzyme replacement therapy (ERT); relation to anti-drug antibody (ADA) status and proteinuria",
      "author": "Warnock",
      "doi-asserted-by": "crossref",
      "first-page": "i634",
      "journal-title": "Nephrol. Dial. Transplant.",
      "key": "10.1016/j.ajhg.2019.02.003_bib45",
      "volume": "33",
      "year": "2018"
    },
    {
      "DOI": "10.1111/j.1365-2249.2004.02567.x",
      "article-title": "Methotrexate reduces antibody responses to recombinant human α-galactosidase A therapy in a mouse model of Fabry disease",
      "author": "Garman",
      "doi-asserted-by": "crossref",
      "first-page": "496",
      "journal-title": "Clin. Exp. Immunol.",
      "key": "10.1016/j.ajhg.2019.02.003_bib46",
      "volume": "137",
      "year": "2004"
    },
    {
      "DOI": "10.1038/mt.2012.64",
      "article-title": "Lentivector transduction improves outcomes over transplantation of human HSCs alone in NOD/SCID/Fabry mice",
      "author": "Pacienza",
      "doi-asserted-by": "crossref",
      "first-page": "1454",
      "journal-title": "Mol. Ther.",
      "key": "10.1016/j.ajhg.2019.02.003_bib47",
      "volume": "20",
      "year": "2012"
    },
    {
      "DOI": "10.2119/molmed.2009.00163",
      "article-title": "Alpha-galactosidase A-Tat fusion enhances storage reduction in hearts and kidneys of Fabry mice",
      "author": "Higuchi",
      "doi-asserted-by": "crossref",
      "first-page": "216",
      "journal-title": "Mol. Med.",
      "key": "10.1016/j.ajhg.2019.02.003_bib48",
      "volume": "16",
      "year": "2010"
    },
    {
      "DOI": "10.1093/glycob/cwg034",
      "article-title": "A biochemical and pharmacological comparison of enzyme replacement therapies for the glycolipid storage disorder Fabry disease",
      "author": "Lee",
      "doi-asserted-by": "crossref",
      "first-page": "305",
      "journal-title": "Glycobiology",
      "key": "10.1016/j.ajhg.2019.02.003_bib49",
      "volume": "13",
      "year": "2003"
    },
    {
      "DOI": "10.1083/jcb.119.5.1137",
      "article-title": "Overexpression of human alpha-galactosidase A results in its intracellular aggregation, crystallization in lysosomes, and selective secretion",
      "author": "Ioannou",
      "doi-asserted-by": "crossref",
      "first-page": "1137",
      "journal-title": "J. Cell Biol.",
      "key": "10.1016/j.ajhg.2019.02.003_bib50",
      "volume": "119",
      "year": "1992"
    },
    {
      "DOI": "10.1083/jcb.98.1.246",
      "article-title": "Hydrolase secretion is a consequence of membrane recycling",
      "author": "Hohman",
      "doi-asserted-by": "crossref",
      "first-page": "246",
      "journal-title": "J. Cell Biol.",
      "key": "10.1016/j.ajhg.2019.02.003_bib51",
      "volume": "98",
      "year": "1984"
    }
  ],
  "reference-count": 51,
  "references-count": 51,
  "resource": {
    "primary": {
      "URL": "https://linkinghub.elsevier.com/retrieve/pii/S0002929719300485"
    }
  },
  "score": 0,
  "short-container-title": [
    "The American Journal of Human Genetics"
  ],
  "source": "Crossref",
  "title": [
    "Systemic mRNA Therapy for the Treatment of Fabry Disease: Preclinical Studies in Wild-Type Mice, Fabry Mouse Model, and Wild-Type Non-human Primates"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1016/elsevier_cm_policy",
  "volume": "104"
}